Universal Ibogaine Inc
XTSX:IBO

Watchlist Manager
Universal Ibogaine Inc Logo
Universal Ibogaine Inc
XTSX:IBO
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: CA$1.6m

Net Margin

-71.7%
Current
Improving
by 18.4%
vs 3-y average of -90%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-71.7%
=
Net Income
-1.5m
/
Revenue
2.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-71.7%
=
Net Income
CA$-1.5m
/
Revenue
2.1m

Peer Comparison

Country Company Market Cap Net
Margin
CA
Universal Ibogaine Inc
XTSX:IBO
1.5m CAD
Loading...
CN
Wenzhou Kangning Hospital Co Ltd
HKEX:2120
694.6m HKD
Loading...
CA
Greenbrook TMS Inc
TSX:GTMS
28.6m CAD
Loading...
US
Ethema Health Corp
OTC:GRST
2.3m USD
Loading...
US
Tocca Life Holdings Inc
OTC:TLIF
367.8k USD
Loading...

Market Distribution

In line with most companies in Canada
Percentile
32st
Based on 4 909 companies
32st percentile
-71.7%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Universal Ibogaine Inc
Glance View

Market Cap
1.6m CAD
Industry
N/A

Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.

IBO Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-71.7%
=
Net Income
-1.5m
/
Revenue
2.1m
What is Universal Ibogaine Inc's current Net Margin?

The current Net Margin for Universal Ibogaine Inc is -71.7%, which is above its 3-year median of -90%.

How has Net Margin changed over time?

Over the last 1 years, Universal Ibogaine Inc’s Net Margin has decreased from -66.9% to -71.7%. During this period, it reached a low of -119.9% on Jan 31, 2025 and a high of -66.9% on Mar 30, 2024.

Back to Top